1AD
Click for more information
0.00% 2.5¢ adalta limited

Ann: SYNThesis BioVentures MoU for cellular immunotherapies, page-51

  1. asx11
    3,320 Posts.
    lightbulb Created with Sketch. 345
    clock Created with Sketch.
    09/04/24
    21:46
    Post #: 73266106
    I am interested to know how they will obtain capital to proceed with trials of all these clinical stage assests. Is SYNBV going to raise capital? Because there is no way Adalta can raise anything substantial at these levels.
    Last edited by asx11: 09/04/24
    1AD Price at posting: 2.7¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS From the Floor: Gold questions answered...
right-arrow Created with Sketch.
NEWS Hillcrest Partners with Ocean Batteries to Deploy ZVS Invert
right-arrow Created with Sketch.
CC9 Chariot Corporation marches forward with discovery-level drill program in Wyoming, USA
right-arrow Created with Sketch.
NEWS MiningNews Select Conference: Inflation and global shifts pose funding challenges for Aus miners
right-arrow Created with Sketch.
NEWS From the Floor question: "Is lithium dead?"
right-arrow Created with Sketch.
NEWS Chris Judd's Talk Ya Book: Tracking Life360 on a journey to the stars
right-arrow Created with Sketch.
watchlist Created with Sketch. Add 1AD (ASX) to my watchlist
(20min delay)
Last
2.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $14.89M
Open High Low Value Volume
2.5¢ 2.5¢ 2.5¢ $850 34K

Buyers (Bids)

No. Vol. Price($)
4 2294371 2.5¢
 

Sellers (Offers)

Price($) Vol. No.
2.6¢ 687066 3
View Market Depth
Last trade - 10.00am 19/06/2024 (20 minute delay) ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.